Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton-Based Stereotactic Ablative Body Radiotherapy (SABR) for Select Patients With Clinically Localized Prostate Cancer.

NCT03159676 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03159676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton-Based Stereotactic Ablative Body Radiotherapy (SABR) for Select Patients With Clinically Localized Prostate Cancer.
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
May 12, 2017
Completion date
December 31, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer